Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories rapid Diagnostics — COVID-19 Testing Sales ($M) ($M)
Form 8-K Quarterly Earnings Releases (Item 2.02 Revenue Tables) & Form 10-K/10-Q MD&A
Latest, Q4 2024
172
Period ended Dec 31, 2024
Change on a year earlier
-37.9%
277 in Q4 2023
History
13 quarters
Since Q4 2021
Sources
9
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Rapid Diagnostics — COVID-19 Testing Sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2024 | Dec 31, 2024 | 172 | -37.9% | SEC Filing (0001628280-25-002092) ↗ |
| Q3 2024 | Sep 30, 2024 | 259 | -11.3% | SEC Filing (0001628280-24-042893) ↗ |
| Q2 2024 | Jun 30, 2024 | 97 | -61.2% | SEC Filing (0001628280-24-032182) ↗ |
| Q1 2024 | Mar 31, 2024 | 197 | -72.0% | SEC Filing (0001628280-24-016497) ↗ |
| Q4 2023 | Dec 31, 2023 | 277 | -72.9% | SEC Filing (0001628280-25-002092) ↗ |
| Q3 2023 | Sep 30, 2023 | 292 | -81.8% | SEC Filing (0001628280-24-042893) ↗ |
| Q2 2023 | Jun 30, 2023 | 250 | -88.8% | SEC Filing (0001628280-24-032182) ↗ |
| Q1 2023 | Mar 31, 2023 | 704 | -76.8% | SEC Filing (0001628280-24-016497) ↗ |
| Q4 2022 | Dec 31, 2022 | 1,022 | -50.9% | SEC Filing (0001628280-24-002009) ↗ |
| Q3 2022 | Sep 30, 2022 | 1,606 | – | SEC Filing (0001628280-23-034544) ↗ |
| Q2 2022 | Jun 30, 2022 | 2,237 | – | SEC Filing (0001628280-23-025156) ↗ |
| Q1 2022 | Mar 31, 2022 | 3,030 | – | SEC Filing (0001628280-23-012020) ↗ |
| Q4 2021 | Dec 31, 2021 | 2,081 | – | SEC Filing (0001628280-23-001516) ↗ |
Breakdown
What makes up rapid diagnostics — covid-19 testing sales ($m)
Cite this data
StockData. (2026). Abbott Laboratories Rapid Diagnostics — COVID-19 Testing Sales ($M) ($M), quarterly Q4 2021–Q4 2024 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/dx-rapid-covid-rev
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.